Now I have a clear picture of where this paper sits relative to its anchors. Let me finalize the review.

**Round 1 bracket:** 4.5–6.5  
**Round 2 narrowing:** The anchors cluster at 5.50 (JQtuCumAFD — the Davidov et al. predecessor, Accept), 5.50 (pVL4bYKOGM — CP for continuous treatments, Reject), 5.80 (AKAz88zYLB — weighted CP for dose-response, Reject), and 6.67 (aJ3tiX1Tu4 — Wasserstein CP under distribution shift, Accept).

**Positioning:** The current paper is comparable to JQtuCumAFD (5.50) in scope and topic — it extends that work to counterfactuals. However, the Equation (1) derivation gap and overstated "exact" claims pull it below the predecessor. It is stronger than AKAz88zYLB (5.80, Reject) on theory (has Theorems 4.1 and 4.2) but weaker on theoretical clarity. It is clearly below aJ3tiX1Tu4 (6.67, Accept). **Final score: 5.0.**

---

## Summary
This paper proposes a conformal prediction method for constructing lower prediction bounds (LPBs) on counterfactual survival times under general right-censoring. The core idea is to transform the coverage probability into a weighted expectation over the subset of data where events are actually observed (W=w, e=1), then apply weighted conformal prediction (Lei & Candès, 2021) for calibration. The paper claims this yields exact marginal coverage guarantees, in contrast to prior PAC-type methods. The method is evaluated on synthetic data (six settings) and an in-house lung cancer dataset (541 patients).

## Strengths
- **Strong outlier robustness (Figure 3, Section 5.1):** Under simulated outlier contamination where 10% of survival times are perturbed by N(1,2), N(10,2), or N(20,2) noise, the proposed method maintains coverage near the nominal 90% level while the PAC-type baselines (Focus and Fused from Davidov et al., 2025) degrade substantially — e.g., dropping below 80% coverage. This is the paper's most compelling empirical finding and genuinely demonstrates a practical advantage of the weighted conformal approach over PAC-type calibration.

- **Theorem 4.1 provides a clean finite-sample bound:** The theorem bounds the coverage gap by ½ 𝔼[|ω̃(X) − ω(X)|], explicitly isolating how weight estimation quality governs coverage validity. The normalization step (redefining ω̃/𝔼[ω̃|𝒟_tr]) is a concrete technical detail that stabilizes the weighted conformal procedure.

- **Doubly robust asymptotic coverage (Theorem 4.2):** Valid coverage holds asymptotically under two alternative sets of conditions — either the weight function is consistently estimated (A1) or the quantile estimator is well-behaved with bounded conditional density (A2). This means a practitioner can obtain valid coverage even if one model component is misspecified.

- **Broad synthetic evaluation (Figure 1):** Across six settings varying censoring and treatment rates, the method consistently achieves near-nominal coverage while producing LPBs competitive with or better than baselines.

## Weaknesses

### Fatal
None.

### Major

- **Equation (1) contains an unjustified step that undermines the paper's central theoretical derivation (Section 4.1, lines 127–138).** Step (ii) multiplies ℙ(T ≤ · | X, W=w) by 1/p(e=1 | X, W=w) and attributes this to the "tower property." The law of iterated expectations does not justify multiplying a conditional probability by the reciprocal of a different conditional probability — this would change the value unless p(e=1 | X, W=w) ≡ 1, which is false in general. Step (iii) then introduces ≤, replacing the marginal probability with a joint probability ℙ(T ≤ ·, e=1 | X, W=w). Since P(A, B) ≤ P(A), the inequality direction would normally be reversed (the joint is smaller). The paper attributes step (iii) to Lemma A.1 (in the stripped appendix) which may contain additional justification, but as presented in the main text the derivation is incorrect. Since Equation (1) is the theoretical bridge from the full-population coverage target to the weighted conformal procedure on the {W=w, e=1} subset, this gap is significant. The method may still work in practice — and the empirical results suggest it does — but the paper's core theoretical argument is not reliable as written.

- **The "exact" coverage guarantee is overstated given Theorem 4.1's error term.** The paper repeatedly contrasts its "exact" guarantee against "PAC-type" guarantees (abstract: "exact miscoverage guarantee"; lines 33, 44: "exact guarantee"; line 112: "exact marginal coverage"). Yet Theorem 4.1 (line 182) gives: ℙ(T(w) ≥ L̃(X)) ≥ 1 − α − ½𝔼[|ω̃(X) − ω(X)|]. This contains an additive error term from weight estimation that is never zero in practice. The paper's strongest finite-sample result depends on weight estimation quality, just as PAC methods' guarantees depend on empirical approximation quality. Both families have approximation gaps of different kinds, and the rhetorical framing of "exact" vs. "PAC" misrepresents what is actually proved. The conceptual distinction (error from weight estimation vs. error from finite-sample approximation) is real but does not justify the term "exact."

### Minor

- **τ-optimization uses the same calibration data as coverage calibration without theoretical justification (lines 162–166).** The paper selects τ*(x) = arg max_τ (q̂_τ^(w)(x) − c_(1−α)^(w)(τ)) using the same calibration set that determines c_(1−α)^(w)(τ). While Theorem 4.1 guarantees coverage for any fixed τ, optimizing τ on the calibration data could introduce selection bias. Standard conformal inference practice requires parameter tuning on a separate split or theoretical accounting for the selection step.

- **Calibration sample size requirements are not discussed.** The method restricts the calibration set to {W_i = w, e_i = 1} (Algorithm 1, line 84). In imbalanced treatment settings with high censoring rates, this set could be very small (e.g., with 541 patients and 30% calibration split, P(W=1, e=1) ≈ 0.12 would yield only ~19 effective calibration samples). The paper does not discuss minimum requirements or failure modes.

- **Theorem 4.2 conditions are strong and hard to verify.** Assumption A2(i) requires the conditional density of T(w)|X to be uniformly bounded away from zero and infinity near the quantile — a smoothness condition that may fail for discrete or mixed outcomes. A2(ii) imposes a specific asymptotic relationship between quantile estimation error and the weight function that practitioners cannot easily check.

- **Limited baseline comparison.** The paper compares against Naive, Focus, and Fused methods (all from the Gui et al. / Davidov et al. PAC-type lineage) but does not experimentally compare against Qi et al. (2024), Meixide et al. (2024), or Qin et al. (2025), which are cited in the related work and address related problems using different paradigms (imputation-based, bootstrap-based).

### Trivial

- **Real-data clinical interpretations are correlational (Section 5.2).** The paper notes that LPB ordering across treatments is "consistent with published clinical findings" (lines 260–261, 282), but does not establish that observed LPB differences reflect genuine causal effects rather than confounding by indication. The authors acknowledge related limitations in the Discussion (line 288), partly mitigating this concern.

## Nice-to-Haves
- Using a public benchmark dataset (e.g., SEER, SUPPORT, TCGA) for at least one real-data experiment would improve reproducibility beyond the in-house dataset.
- A sensitivity analysis showing how coverage degrades as the effective calibration set shrinks would address the sample size concern.
- A theoretical analysis of the τ-optimization step (or validation on a separate split) would strengthen the method's rigor.

## Removed Points
These points are flagged to be removed, treat them with caution.

- *Harsh Critic: "cannot verify since the appendix was stripped"* — Per hard rules, criticisms that depend on the stripped appendix being unavailable are removed. The retained Equation (1) criticism stands on its own from the main-text derivation, independent of whether Lemma A.1 fixes it.
- *Harsh Critic: "The dataset is an in-house collection… not a public benchmark, which limits reproducibility"* — Moved to Nice-to-Haves rather than treated as a core weakness. The dataset is real and the paper describes it; a public benchmark would enhance but is not required.
- *Strength Finder: "Identifiable upper-bound derivation enabling exact coverage (Equation 1)"* — This strength is invalid because Equation (1) contains an unjustified step (see Major Weakness #1). Dropped.
- *Strength Finder: generic statements about "important problem" and "interesting question"* — Dropped as superficial.

## Novel Insights
The paper's most novel empirical insight is that weighted conformal prediction on the uncensored subset produces LPBs that are substantially more robust to outliers than PAC-type calibration methods (Figure 3). This suggests that exact marginal coverage — even with weight estimation error — provides practical robustness benefits that PAC-type guarantees do not capture, a finding with implications beyond this paper's specific survival-analysis setting.

## Suggestions
- **Fix or replace the derivation in Equation (1).** If the intended result is an upper bound (α ≤ weighted expectation over {W=w, e=1}), make the inequality direction explicit and provide a valid justification. If Lemma A.1 provides the correct derivation, sketch the key steps in the main text rather than relying on an unjustified "tower property" step.
- **Replace "exact" language throughout** with precise statements: e.g., "coverage guarantee with explicit weight-estimation error bound" rather than "exact coverage guarantee." The finite-sample bound in Theorem 4.1 is genuinely distinct from PAC-type guarantees in character but is not "exact."
- **Either justify the τ-optimization** theoretically (e.g., via a union bound over a grid of τ values) or validate τ on a separate split from the calibration data.

## Score and Decision

**Anchor comparison summary:**

| Anchor | Score | Decision | Round | Comparison |
|--------|-------|----------|-------|------------|
| JQtuCumAFD (Davidov et al. 2025) | 5.50 | Accept | R1/R2 | Direct predecessor; current paper adds counterfactuals and "exact" claim but has Eq. (1) gap. Slightly weaker. |
| pVL4bYKOGM | 5.50 | Reject | R1/R2 | CP for continuous treatments; similar theoretical contribution level. Comparable. |
| AKAz88zYLB | 5.80 | Reject | R1/R2 | Weighted CP for dose-response; no theoretical guarantees. Current paper stronger on theory. |
| aJ3tiX1Tu4 | 6.67 | Accept | R2 | Wasserstein CP under distribution shift; much stronger theory and cleaner execution. Current paper clearly below. |

**Round 1 bracket:** 4.5–6.5  
**Round 2 narrowing:** The current paper sits below JQtuCumAFD (5.50) due to the unjustified derivation and overstated claims, but above the ~4.0 weak-reject tier due to solid empirical results and genuine theoretical contributions (Theorems 4.1, 4.2).

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>